Virtual Medicinal Product (VMP) - Agalsidase beta 5mg powder for solution for infusion vials

Navigation

Name Details

Name Start Date End Date
Current Name Agalsidase beta 5mg powder for solution for infusion vials 13-01-2009
Previous Name Agalsidase beta 5mg powder for solution for injection vials 05-09-2005 12-01-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
vial
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intravenous
Form
Powder for solution for infusion
Ontology Form/Route
solutioninfusion.intravenous
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
A16AB04
BNF Start Date End Date
Current BNF 09080100 Start Date 04-04-2022 End Date
Previous BNF 09080100 Start Date 05-09-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
41758111000001109 09-05-2023
413468006 08-09-2005 08-05-2023

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Agalsidase beta Based on Ingredient Substance 5 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial